Tag: Chemotherapy

Rate of event-free survival higher with neoadjuvant pembrolizumab plus chemo versus chemo alone for early triple-negative breast cancer

Overall survival longer in patients receiving first-line treatment with nivolumab plus chemo or nivolumab plus ipilimumab versus chemo alone

Polygenic score based on single nucleotide polymorphisms in the ara-C pathway genes may predict treatment outcomes

Progression-free, overall survival prolonged with lenvatinib plus pembrolizumab versus treating physician's choice of chemotherapy

Overall survival, progression-free survival prolonged in those receiving durvalumab versus placebo in addition to gemcitabine and cisplatin

Overall survival longer with secondary cytoreductive surgery followed by platinum-based chemotherapy versus chemotherapy alone

However, many patients experience improvements in hair density with standard alopecia treatments

Progression-free and overall survival significantly longer for patients with persistent, recurrent, metastatic cervical cancer

Risk for thrombosis doubled if catheter-to-vein ratio exceeds 45 percent for peripherally inserted central catheter

Vincristine and dexamethasone pulses might be eliminated during second year of treatment for children with low-risk disease